Tempus One

Tempus One is a generative AI-enabled clinical assistant designed specifically for oncology providers. Available within Tempus Hub and directly integrated into the EHR, Tempus One gives clinicians voice and text-based access to patient data, genomic reports, clinical trial information, and treatment support tools at the point of care—anytime and anywhere.

Tempus One is built to help oncology providers make faster, more informed clinical decisions by surfacing the right patient insights without requiring manual chart navigation. Whether in the clinic, in the community setting, or on the go, Tempus One streamlines access to critical information and reduces administrative burden across the care journey.

Core Capabilities Available in Tempus Hub and EHR

• Quick access to patient order status and reports: Retrieve report information on actionable biomarkers and receive real-time updates on the status of a patient's genomic report.
• Summarized patient history, treatment journey, and biomarker status: Enter each appointment prepared with a comprehensive summary of the patient's clinical context, enabling faster and more informed decision-making.
• Up-to-date clinical trial information: Search for relevant clinical trials based on specific patient enrollment criteria directly within the assistant.
• Quick lookup of patient medical history: Query specific moments in a patient's medical history from clinical notes and records, including prior therapies, pathology reports, and radiology results.
• Streamline prior authorizations and follow-up care: Get assistance preparing prior authorizations and anticipating next steps to keep care moving forward without delay.
• Connect with a live representative: If Tempus One cannot answer a question, users are connected with a Tempus representative in real time.

Additional Capabilities Available Exclusively in the EHR

• Rapid filtering of patient incidence by alteration, gene, or diagnosis: Review relevant patient cohorts to gain additional insight for clinical decision-making across a provider's patient population.
• Effortless documentation during every visit: Receive real-time transcriptions and intelligent notes of appointments that can be saved directly to the patient's chart.
• Request test add-ons for an order: Add confirmatory germline tests such as xG or xG+, algorithmic tests like HRD, or IHC tests, and cancel existing orders directly through the assistant.

What Oncology Providers Are Saying

• Thomas George, MD, FACP, of the University of Florida Cancer Center, describes Tempus One as intuitive and easy to use, noting it helps efficiently retrieve real-time NGS answers in the clinic without the burden of digging through charts or individual reports.
• Sandip Patel, MD, of UC San Diego Health, highlights how Tempus One simplifies the complex process of ordering, obtaining, and interpreting genomic testing, and demonstrates the power of AI-assisted precision oncology for direct clinical benefit.
• Kamal Sharma, DO, of The Oncology Institute in Lakeland, FL, describes Tempus One as a platform that enables personalized patient care in any setting and calls it the future of oncology.

Tempus One is accessible through Tempus Hub as well as via EHR integration, enabling providers to engage with the assistant in their existing clinical workflows. Providers interested in accessing Tempus One within their EHR environment can request access directly through Tempus.